These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 2905529)

  • 41. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
    Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
    Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroleptics, dopamine, and schizophrenia.
    Pickar D
    Psychiatr Clin North Am; 1986 Mar; 9(1):35-48. PubMed ID: 2870480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Dopanergic agonists and schizophrenia].
    Pidgeon JF; Wolf MA
    Psychiatr J Univ Ott; 1989 Nov; 14(4):529-35. PubMed ID: 2573101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An un-dopamine hypothesis of schizophrenia.
    Alpert M; Friedhoff AJ
    Schizophr Bull; 1980; 6(3):387-9. PubMed ID: 6105705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholecystokinin, dopamine and schizophrenia.
    Garver DL; Beinfeld MC; Yao JK
    Psychopharmacol Bull; 1990; 26(3):377-80. PubMed ID: 2274639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue.
    Memo M; Missale C; Carruba MO; Spano PF
    J Neural Transm Suppl; 1986; 22():19-32. PubMed ID: 2431109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Schizophrenia and dopamine receptors.
    Seeman P
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):999-1009. PubMed ID: 23860356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The mesencephalic dopaminergic system. Implications for neuroleptic treatment].
    Beaufils B
    Encephale; 1990; 16(3):167-74. PubMed ID: 1974842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma homovanillic acid, serum anti-D1 and anti-D2 receptor activity, and psychopathology in chronic schizophrenia.
    Koshikawa H; Suzuki E; Kanba S; Nibuya M; Ishizuki T; Kohno H; Kinoshita N; Shintani F; Yagi G; Nakaki T
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):79-81. PubMed ID: 1679276
    [No Abstract]   [Full Text] [Related]  

  • 51. [Role of dopamine receptors in the mechanism of action of neuroleptics].
    Lavretskaia EF; Kats MM; Baldenkov GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):431-5. PubMed ID: 2859724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The two-syndrome concept and neuroendocrinology of schizophrenia.
    Crow TJ; Ferrier IN; Johnstone EC
    Psychiatr Clin North Am; 1986 Mar; 9(1):99-113. PubMed ID: 2870481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting the dopamine D2 receptor in schizophrenia.
    Seeman P
    Expert Opin Ther Targets; 2006 Aug; 10(4):515-31. PubMed ID: 16848689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
    Seeman P; Ulpian C; Bergeron C; Riederer P; Jellinger K; Gabriel E; Reynolds GP; Tourtellotte WW
    Science; 1984 Aug; 225(4663):728-31. PubMed ID: 6147018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A controlled comparative study of chlorprothixene vs. haloperidol in chronic schizophrenia.
    Fux M; Belmaker RH
    Isr J Psychiatry Relat Sci; 1991; 28(1):37-40. PubMed ID: 1830565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dopamine systems in the brain, functional classification of different dopamine receptors.
    Ljungberg T
    Acta Psychiatr Belg; 1987; 87(5):523-34. PubMed ID: 2897758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism.
    Seeman P; Corbett R; Nam D; Van Tol HH
    Jpn J Pharmacol; 1996 Jul; 71(3):187-204. PubMed ID: 8854201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoaminergic synapses and schizophrenia: 45 years of neuroleptics.
    Bennett MR
    J Psychopharmacol; 1998; 12(3):289-304. PubMed ID: 10958257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The dopamine/neuroleptic receptor.
    Grigoriadis D; Seeman P
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):108-13. PubMed ID: 6231978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.
    Coward D; Dixon K; Enz A; Shearman G; Urwyler S; White T; Karobath M
    Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.